- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03689322
Effects of WBV Associated With IMT on Inflammatory Markers, Body Composition, Muscle Strength and Thickness
September 24, 2019 updated by: Helga Cecília Muniz de Souza, Universidade Federal de Pernambuco
Effects of Whole Body Vibration Associated With the Inspiratory Muscle Training Program on Inflammatory Markers, Body Composition, Muscle Strength and Thickness
Aging generates immune, muscular and functional changes.
In the pre-frail elderly these changes may be increased and, therefore, preventive interventions are indicated to minimize the consequences of sarcopenia in this population.
This study aims to evaluate the effects of a whole body vibration training associated with the training of inspiratory muscles on the inflammatory, muscular and body composition outcomes in pre-frail elderly women.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
42
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pernambuco
-
Recife, Pernambuco, Brazil
- Federal University of Pernambuco
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Elderly individuals able to walk without assistance
- Good understanding to carry out the proposed tests, evaluated through the Mini Mental State Examination (MMSE).
Exclusion Criteria:
- Contraindication or difficulty to perform evaluation procedures
- Users of medications that interfere with the cardiovascular and / or muscular system
- Smokers
- Neuromuscular or degenerative diseases
- Pulmonary comorbidities
- Heart diseases
- Labyrinthitis.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: WBV + IMT
Whole body vibration training associated with respiratory muscle training (WBV + IMT)
|
The whole body vibration training will be performed through a vibrating platform with three axes and vibration frequency set at 35 Hz.
The amplitude used will be 02 to 04 mm.The inspiratory muscle training will be performed through a device that provides inspiratory resistance.
|
Active Comparator: WBV + IMTsham
Whole body vibration training associated with respiratory muscle training sham (WBV + IMTsham)
|
The whole body vibration training will be performed through a vibrating platform with three axes and vibration frequency set at 35 Hz.
The amplitude used will be 02 to 04 mm.The inspiratory muscle training sham will be performed through a device without inspiratory resistance.
|
Sham Comparator: WBVsham + IMTsham
Whole body vibration training sham associated with respiratory muscle training sham (WBVsham + IMTsham)
|
Whole body vibration training will be performed through a vibrating platform coupled to a device that generates non-therapeutic low frequency vibration.
The simulation of inspiratory muscle training will be performed through a device with no inspiratory resistance.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Respiratory Muscle Strength and Resistance
Time Frame: Change from Baseline respiratory muscle strength and resistance at 3 months
|
Maximum Inspiratory and Expiratory Pressure will be evaluated through manovacuometer
|
Change from Baseline respiratory muscle strength and resistance at 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Thickness of the quadriceps muscle
Time Frame: Change from Baseline thickness of the quadriceps muscle at 3 months
|
Ultrasound will be used to assess the thickness of the quadriceps muscle according to the pre-established protocol.
|
Change from Baseline thickness of the quadriceps muscle at 3 months
|
Diaphragmatic thickness
Time Frame: Change from Baseline diaphragmatic thickness at 3 months
|
Ultrasound will to use to evaluate diaphragm thickness non-invasively in the zone of apposition during tidal breathing and with changes in lung volume.
|
Change from Baseline diaphragmatic thickness at 3 months
|
Diaphragmatic mobility
Time Frame: Change from Baseline diaphragmatic mobility at 3 months
|
During respiration to total lung capacity, measurement of the diaphragmatic excursion will be assessed by ultrasonography.
|
Change from Baseline diaphragmatic mobility at 3 months
|
Body Composition
Time Frame: Change from Baseline body composition at 3 months
|
Body composition will be evaluated through bioimpedance balance
|
Change from Baseline body composition at 3 months
|
Inflammatory markers
Time Frame: Change from Baseline inflammatory markers at 3 months
|
Blood concentration of Interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha) and brain-derived neurotrophic factor (BDNF) will be assessed through blood plasma sample.
|
Change from Baseline inflammatory markers at 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2018
Primary Completion (Actual)
May 30, 2019
Study Completion (Actual)
July 30, 2019
Study Registration Dates
First Submitted
September 25, 2018
First Submitted That Met QC Criteria
September 26, 2018
First Posted (Actual)
September 28, 2018
Study Record Updates
Last Update Posted (Actual)
September 25, 2019
Last Update Submitted That Met QC Criteria
September 24, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- WBV on inflammatory biomarkers
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frail Elderly Syndrome
-
DSM Nutritional Products, Inc.CompletedFrail Elderly | Pre-frail ElderlyNetherlands
-
McMaster UniversityAlberta Health services; Saskatchewan Health Authority - Regina Area; Canadian... and other collaboratorsActive, not recruitingFrail Elderly SyndromeCanada
-
Università degli Studi del Piemonte Orientale "Amedeo...Completed
-
University of Massachusetts, WorcesterAnesthesia Patient Safety FoundationCompleted
-
School of Health Sciences GenevaInstitution genevoise de maintien à domicileCompletedFrail Elderly Syndrome
-
University of GlasgowNHS Greater Glasgow and ClydeUnknownFrail Elderly SyndromeUnited Kingdom
-
Castilla-La Mancha Health ServiceColegio Oficial de Terapeutas Ocupacionales de Castilla - La Mancha; Fundación... and other collaboratorsRecruiting
-
Federico II UniversityRecruiting
-
Guang Yang, Prof. Dr.CompletedFrail Elderly SyndromeChina
Clinical Trials on WBV + IMT
-
Universidade Federal de PernambucoCompleted
-
Universidade Federal do Rio Grande do NorteCompletedNeuromuscular Performance and BalanceBrazil
-
Universidade Federal do Rio Grande do NorteCompletedNeuromuscular Performance and BalanceBrazil
-
Istanbul Physical Medicine Rehabilitation Training...CompletedMuscle Spasticity | PhysiologyTurkey
-
Chinese University of Hong KongRecruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Tear | Patellofemoral PainHong Kong
-
University of Illinois at ChicagoTÜBİTAKNot yet recruitingCABG | Coronary Artery Bypass GraftUnited States
-
Bagcilar Training and Research HospitalCompletedEffects of Vibration | Bone MassTurkey
-
The Hong Kong Polytechnic UniversityCompleted
-
Universidad Rey Juan CarlosCompleted